EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses

Will Macnair, Daniela Calini, Eneritz Agirre, Julien Bryois, Sarah Jäkel, Rebecca Sherrard Smith, Petra Kukanja, Nadine Stokar-Regenscheit, Virginie Ott, Lynette C Foo, Ludovic Collin, Sven Schippling und 12 weitere

Neuron · 2025-02 · 113 (3) · 396-410.e9

DOI: 10.1016/j.neuron.2024.11.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2025-02. Verfasst von Will Macnair und 23 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center, Basel, Switzerland. Electronic address: will.ma…. Hauptthemen laut MEDLINE: White Matter, Multiple Sclerosis, Neuroglia, RNA, Small Nuclear. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Svenska Forskningsrådet Formas, Knut and Alice Wallenberg Foundation, Swedish Brain Power.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor understanding of the cellular and molecular basis of clinical and genetic heterogeneity in progressive multiple sclerosis (MS) has hindered the search for new effective therapies. To address this gap, we analyzed 632,000 single-nucleus RNA sequencing profiles from 156 brain tissue samples of MS and control donors to examine inter- and intra-donor heterogeneity. We found distinct cell type-specific gene expression changes between MS gray and white matter, highlighting clear pathology differences. MS lesion subtypes had different cellular compositions but surprisingly similar cell-type gene expression patterns both within and across patients, suggesting global changes. Most gene expression variability was instead explained by patient effects, allowing us to stratify patients and describe the different pathological processes occurring between patient subgroups. Future mapping of these brain molecular profiles with blood and/or CSF profiles from living MS patients will allow precision medicine approaches anchored in patient-specific pathological processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

White MatterMultiple SclerosisNeurogliaRNA, Small NuclearHumansFemaleMaleAdultMiddle AgedGray MatterRNA-SeqSequence Analysis, RNABrain

Stichwörter der Autor:innen

demyelinationgray mattermultiple sclerosispatient stratificationprogressive MSregenerationremyelinationsnRNA-seqwhite matter

Substanzen

RNA, Small Nuclear

Autor:innen und Institutionen

  • Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center, Basel, Switzerland. Electronic address: will.macnair@roche.com.
  • Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center, Basel, Switzerland.
  • Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17177 Stockholm, Sweden.
  • Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München, Ludwig-Maximilians Universität, Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
  • Centre for Regenerative Medicine, Institute for Regeneration and Repair, MS Society Edinburgh Centre for MS Research, The University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
  • Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Pathology and Applied Safety Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerlan…

Förderung

  • Svenska Forskningsrådet Formas
  • Knut and Alice Wallenberg Foundation
  • Swedish Brain Power
  • Swedish Society for Medical Research
  • UK Research and Innovation Medical Research Council
  • European Research Council
  • European Commission Marie Sklodowska-Curie Actions
  • Multiple Sclerosis Society

Zitieren

APA

Macnair, W., Calini, D., Agirre, E., Bryois, J., Jäkel, S., Smith, R. S., Kukanja, P., Stokar-Regenscheit, N., Ott, V., Foo, L. C., Collin, L., Schippling, S., Urich, E., Nutma, E., Marzin, M., Ansaloni, F., Amor, S., Magliozzi, R., Heidari, E., …, & Malhotra, D. (2025). snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses. Neuron, 113(3), 396-410.e9. https://doi.org/10.1016/j.neuron.2024.11.016

Vancouver

Macnair W, Calini D, Agirre E, Bryois J, Jäkel S, Smith RS, et al. snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses. Neuron. 2025;113(3):396-410.e9. doi:10.1016/j.neuron.2024.11.016

BibTeX
@article{Macnair2025,
  author = {Macnair, Will and Calini, Daniela and Agirre, Eneritz and Bryois, Julien and Jäkel, Sarah and Smith, Rebecca Sherrard and Kukanja, Petra and Stokar-Regenscheit, Nadine and Ott, Virginie and Foo, Lynette C and Collin, Ludovic and Schippling, Sven and Urich, Eduard and Nutma, Erik and Marzin, Manuel and Ansaloni, Federico and Amor, Sandra and Magliozzi, Roberta and Heidari, Elyas and Robinson, Mark D and Ffrench-Constant, Charles and Castelo-Branco, Gonçalo and Williams, Anna and Malhotra, Dheeraj},
  title = {snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses},
  journal = {Neuron},
  year = {2025},
  volume = {113},
  number = {3},
  pages = {396--410.e9},
  doi = {10.1016/j.neuron.2024.11.016}
}
Kostenlos starten →